Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1992;12:237-249

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vijayagopal, P.
Right arrow Articles by Berenson, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vijayagopal, P.
Right arrow Articles by Berenson, G. S.

Arteriosclerosis and Thrombosis, Vol 12, 237-249, Copyright © 1992 by American Heart Association


ARTICLES

Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages

P Vijayagopal, SR Srinivasan, B Radhakrishnamurthy and GS Berenson
Department of Medicine, Lousiana State University Medical Center, New Orleans 70112.

Lipoprotein-proteoglycan complexes from human atherosclerotic lesions were studied to determine their ability to stimulate cholesteryl ester accumulation in human monocytes/macrophages. Complexes containing apolipoprotein (apo) B lipoproteins and proteoglycans were extracted from fatty streaks and fibrous plaque lesions of human aortas by extraction with 0.15 M NaCl. Fractionation of the complex with Bio-Gel A-50m yielded a single fraction from fatty streaks and two fractions from fibrous plaques. The complexes were further purified by anti-apo B affinity chromatography and analyzed for apolipoproteins, lipids, and glycosaminoglycans Apo B was the only apolipoprotein present in the complexes. Although the complexes from fatty streaks and fibrous plaques contained varying proportions of hyaluronic acid, chondroitin 6- sulfate, and dermatan sulfate, heparin was present in only the fibrous plaque complexes. All three lipoprotein-proteoglycan complexes increased the rate of incorporation of [14C]oleate into cholesteryl [14C]oleate and stimulated cholesteryl ester accumulation in monocytes/macrophages. However, the complexes from fibrous plaques were more potent than those from fatty streaks in this regard. Cholesteryl ester synthesis that is mediated by the uptake of the complexes was dose dependent and showed apparent saturation, suggesting that cell surface binding may be required. Chloroquine, a lysosomotropic agent, inhibited cholesteryl ester synthesis that is induced by the complexes, indicating that lysosomal hydrolysis was essential. Cholesteryl ester synthesis that is mediated by the complexes was inhibited 70-79% by polyinosinic acid. Furthermore, excess unlabeled fibrous plaque complexes significantly inhibited the binding and internalization of in vitro 125I-low density lipoprotein (LDL)-proteoglycan complexes and 125I-acetylated-LDL and not 125I-LDL. These results suggest the involvement of the scavenger receptor in the uptake of the complexes. Phagocytosis played a minor role in the metabolism of these ligands because cytochalasin D inhibited cholesteryl ester synthesis, which is mediated by fibrous plaque complexes, by 7.5-25%. Cholesteryl ester synthesis increased linearly over 32 hours in macrophages incubated with the complexes, indicating an apparent lack of downregulation of binding sites. This resulted in the appearance of intracellular oil red O-positive lipid droplets. These studies show for the first time that apo B lipoprotein-proteoglycan complexes isolated from human atherosclerotic lesions can induce cholesteryl ester accumulation in monocytes/macrophages.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kaplan and M. Aviram
Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages : An Alternative Approach to Study Lipoproteins Cellular Uptake
Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 386 - 393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Schwenke
Metabolic evidence for sequestration of low-density lipoprotein in abdominal aorta of normal rabbits
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1128 - H1140.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Lundstam, E. Hurt-Camejo, G. Olsson, P. Sartipy, G. Camejo, and O. Wiklund
Proteoglycans Contribution to Association of Lp(a) and LDL With Smooth Muscle Cell Extracellular Matrix
Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1162 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Oorni, J. K. Hakala, A. Annila, M. Ala-Korpela, and P. T. Kovanen
Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles. TWO DISTINCT MECHANISMS LEADING TO INCREASED BINDING STRENGTH OF LDL TO HUMAN AORTIC PROTEOGLYCANS
J. Biol. Chem., October 30, 1998; 273(44): 29127 - 29134.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Daugherty, J. A. Cornicelli, K. Welch, S. M. Sendobry, and D. L. Rateri
Scavenger Receptors are Present on Rabbit Aortic Endothelial Cells In Vivo
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2369 - 2375.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Manning, I. J. Edwards, W. D. Wagner, J. D. Wagner, M. R. Adams, and J. S. Parks
Effects of Contraceptive Estrogen and Progestin on the Atherogenic Potential of Plasma LDLs in Cynomolgus Monkeys
Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1216 - 1223.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Shi, J. E. O'Brien Jr, J. D. Mannion, R. C. Morrison, W. Chung, A. Fard, and A. Zalewski
Remodeling of Autologous Saphenous Vein Grafts : The Role of Perivascular Myofibroblasts
Circulation, June 17, 1997; 95(12): 2684 - 2693.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, and G. Camejo
Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans: Potential Contribution to Atherogenesis
Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1011 - 1017.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Vijayagopal and D. L. Glancy
Macrophages Stimulate Cholesteryl Ester Accumulation in Cocultured Smooth Muscle Cells Incubated With Lipoprotein-Proteoglycan Complex
Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1112 - 1121.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Wang, K. A. Lindstedt, and P. T. Kovanen
Mast Cell Granule Remnants Carry LDL Into Smooth Muscle Cells of the Synthetic Phenotype and Induce Their Conversion Into Foam Cells
Arterioscler Thromb Vasc Biol, June 1, 1995; 15(6): 801 - 810.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Paananen, J. Saarinen, A. Annila, and P. T. Kovanen
Proteolysis and Fusion of Low Density Lipoprotein Particles Strengthen Their Binding to Human Aortic Proteoglycans
J. Biol. Chem., May 19, 1995; 270(20): 12257 - 12262.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Williams and I. Tabas
The Response-to-Retention Hypothesis of Early Atherogenesis
Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 551 - 561.
[Full Text]